Thrombolex
Manufacturing · Pennsylvania, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
75 Britain Dr, New Britain, Pennsylvania...Phone Number
(844) 792-6300Website
www.thrombolex.comRevenue
$7.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Thrombolex
Thrombolex is a medical device company engaged in the design, development, and distribution of innovative endovascular catheters used in interventional procedures, particularly in catheter-directed thrombolysis (CDT) of thrombus in patients who suffer from arterial, venous, and arteriovenous thromboembolic conditions. Founded in 2016, Thrombolex is headquartered in Doylestown, Pennsylvania.Explore more
Thrombolex Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Thrombolex your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Click to see if Thrombolex had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Thrombolex has new funding data
Check if Thrombolex has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Thrombolex recently announced quarterly report
Product Launch: Get notified when Thrombolex launches new products
Check out if Thrombolex is spiking on competitors!
Thrombolex, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Thrombolex
Recommended Actions
Reach out to Masked Content who joined Thrombolex as Masked Content
Find more new buyers
Compare Similar Companies to Thrombolex
Compare insights from companies similar to Thrombolex, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
51-200
Private
<$5M
2013
MC
Michelle ConlonDirector, Ancillary Services Cardiac & Vascular Diagnostic Medical Sonographer
Company Profile Activity
Activity Insights
Thrombolex is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Thrombolex is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Thrombolex.
Thrombolex financials insights
Gather financial insights about Thrombolex, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2026
Series A
$50M
Thrombolex Tech Stack
A closer look at the technologies used by Thrombolex
Most Recent Scoops
Funding
Funding
Person-Based
Person-Based
Promotion
Executive Move
Lateral Move
Executive Move
Board of Directors
Thrombolex News & Media
Thrombolex Announces Enrollment of 100th Patient in RAPID-PE Clinical Study
Thrombolex, Inc., today announced the enrollment of the 100th patient in the RAPID-PE clinical study. This significant milestone underscores the growing clinical confidence in the BASHIR® Endovascular System and the urgency of generating robust evidence for the treatment of intermediate-risk pulmonary embolism (PE). [PR.com]Thrombolex, Inc. Secures $50 Million Series A Growth Financing
Thrombolex, Inc. Secures $50 Million Series A Growth Financing to Advance Commercialization of its Innovative Pharmaco-Mechanical Lysis Technology (PML). Thrombolex, a commercial-stage medical device company advancing a differentiated pharmaco-mechanical lysis (PML) platform for the treatment of pulmonary embolism (PE) and other thromboembolic diseases, announced the closing of a $50 million Series A equity financing led [PR.com]Thrombolex RAPID-PE Interim Analysis
THROMBOLEX™, Inc. presented the prespecified interim analysis from the first 50 patients in RAPID-PE during an Innovation Session at TCT, in San Francisco. [PR.com]RESCUE-II Study Results Demonstrate Safety and Feasibility of the BASHIR™ Endovascular Catheter (BEC) in Treating Pulmonary Embolism (PE) On-The-Table (OTT)
Thrombolex, Inc., a medical device manufacturer committed to advancing solutions for the treatment of arterial and venous thromboembolic diseases, announced the publication of the results from the RESCUE-II Study in JACC: Advances. [PR.com]
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Thrombolex
Sign Up For FreeTo access detailed company insights
Thrombolex is a medical device company engaged in the design, development, and distribution of innovative endovascular catheters used in interventional procedures, particularly in catheter-directed thrombolysis (CDT) of thrombus in patients who suffer from arterial, venous, and arteriovenous thromboembolic conditions. Founded in 2016, Thrombolex is... Read More
